[en] Neuroinflammation is a hallmark of Amyotrophic Lateral Sclerosis (ALS) in hSOD1G93A mouse models where microglial cells contribute to the progressive motor neuron degenerative process. S100-A8 and S100-A9 (also known as MRP8 and MRP14, respectively) are cytoplasmic proteins expressed by inflammatory myeloid cells, including microglia and macrophages. Mainly acting as a heterodimer, S100-A8/A9, when secreted, can activate Toll-like Receptor 4 on immune cells, leading to deleterious proinflammatory cytokine production. Deletion of S100a9 in Alzheimer's disease mouse models showed a positive outcome, reducing pathology. We now assessed its role in ALS. Unexpectedly, our results show that deleting S100a9 in hSOD1G93A ALS mice had no impact on mouse survival, but rather accelerated symptoms with no impact on microglial activation and motor neuron survival, suggesting that blocking S100-A9 would not be a valuable strategy for ALS.
Disciplines :
Neurologie
Auteur, co-auteur :
Ribon, Matthieu; Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Paris, France
Leone, Céline; Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Paris, France
Chiot, Aude; Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Paris, France
Berriat, Félix; Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Paris, France
Rampanana, Martine ; Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Paris, France
Cottin, Julie; Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Paris, France
Bohl, Delphine; Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Paris, France
Millecamps, Stéphanie ; Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Paris, France
Lobsiger, Christian S; Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Paris, France
HENEKA, Michael ; Department of Neurodegenerative Disease and Gerontopsychiatry/Neurology, University of Bonn Medical Center, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
Boillée, Séverine; Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Paris, France. Electronic address: severine.boillee@sorbonne-universite.fr
Co-auteurs externes :
yes
Langue du document :
Anglais
Titre :
Deletion of the inflammatory S100-A9/MRP14 protein does not influence survival in hSOD1G93A ALS mice.
We kindly thank Pr. Thomas Vogl (Institute of Immunolgy Münster, Germany), Drs. Olivier Dussurget and Marie-Anne Nahori (Pasteur Institute, Paris, France) for providing S100a9-/- mice. We thank the technical staff from our animal housing facility (UMS28, Centre d'expérimentation fonctionnelle, Paris, France) and the following ICM core facilities (Paris, France): iGenSeq, Histomics, ICM.Quant (which received ANR-10-IAIHU-06 funding). This study was funded by: ERA-NET NEURON (ANR-14-NEUR-0003-02), ARSLA, Fondation Thierry Latran, NRJ-Institut de France, l'ARMC, S.L.A.F.R., 'La longue route des malades de la SLA', 'Un pied devant l'autre' and private donors to ALS at the ICM.We kindly thank Pr. Thomas Vogl (Institute of Immunolgy M?nster, Germany), Drs. Olivier Dussurget and Marie-Anne Nahori (Pasteur Institute, Paris, France) for providing S100a9-/- mice. We thank the technical staff from our animal housing facility (UMS28, Centre d'exp?rimentation fonctionnelle, Paris, France) and the following ICM core facilities (Paris, France): iGenSeq, Histomics, ICM.Quant (which received ANR-10-IAIHU-06 funding). This study was funded by: ERA-NET NEURON (ANR-14-NEUR-0003-02), ARSLA, Fondation Thierry Latran, NRJ-Institut de France, l'ARMC, S.L.A.F.R. 'La longue route des malades de la SLA', 'Un pied devant l'autre' and private donors to ALS at the ICM.
Akiyama, H., Ikeda, K., Katoh, M., McGeer, E.G., McGeer, P.L., Expression of MRP14, 27E10, interferon-alpha and leukocyte common antigen by reactive microglia in postmortem human brain tissue. J. Neuroimmunol. 50 (1994), 195–201.
Beers, D.R., Henkel, J.S., Xiao, Q., Zhao, W., Wang, J., Yen, A.A., Siklos, L., McKercher, S.R., Appel, S.H., Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A. 103 (2006), 16021–16026.
Boillée, S., Yamanaka, K., Lobsiger, C.S., Copeland, N.G., Jenkins, N.A., Kassiotis, G., Kollias, G., Cleveland, D.W., Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312 (2006), 1389–1392.
Chiot, A., Zaïdi, S., Iltis, C., Ribon, M., Berriat, F., Schiaffino, L., Jolly, A., de la Grange, P., Mallat, M., Bohl, D., Millecamps, S., Seilhean, D., Lobsiger, C.S., Boillée, S., Modifying macrophages at the periphery has the capacity to change microglial reactivity and to extend ALS survival. Nat. Neurosci. 23 (2020), 1339–1351.
Donato, R., Cannon, B.R., Sorci, G., Riuzzi, F., Hsu, K., Weber, D.J., Geczy, C.L., Functions of S100 proteins. Curr. Mol. Med. 13 (2013), 24–57.
Ehrchen, J.M., Sunderkötter, C., Foell, D., Vogl, T., Roth, J., The endogenous Toll–like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J. Leukocyte Biol. 86 (2009), 557–566.
Gurney, M.E., Pu, H., Chiu, A.Y., Dal Canto, M.C., Polchow, C.Y., Alexander, D.D., Caliendo, J., Hentati, A., Kwon, Y.W., Deng, H.X., Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264 (1994), 1772–1775.
Ha, T.-Y., Chang, K.-A., Kim, J.a, Kim, H.-S., Kim, S., Chong, Y.H., Suh, Y.-H., S100a9 knockdown decreases the memory impairment and the neuropathology in Tg2576 mice, AD animal model. PLoS One, 5, 2010, e8840.
Kim, H.J., Chang, K.-A., Ha, T.-Y., Kim, J., Ha, S., Shin, K.-Y., Moon, C., Nacken, W., Kim, H.-S., Suh, Y.-H., S100A9 knockout decreases the memory impairment and neuropathology in crossbreed mice of Tg2576 and S100A9 knockout mice model. PLoS One, 9, 2014, e88924.
Kummer, M.P., Vogl, T., Axt, D., Griep, A., Vieira-Saecker, A., Jessen, F., Gelpi, E., Roth, J., Heneka, M.T., Mrp14 deficiency ameliorates amyloid β burden by increasing microglial phagocytosis and modulation of amyloid precursor protein processing. J. Neurosci. 32 (2012), 17824–17829.
Lodeiro, M., Puerta, E., Ismail, M.-A.-M., Rodriguez-Rodriguez, P., Rönnbäck, A., Codita, A., Parrado-Fernandez, C., Maioli, S., Gil-Bea, F., Merino-Serrais, P., Cedazo-Minguez, A., Aggregation of the inflammatory S100A8 precedes Aβ Plaque formation in transgenic APP mice: positive feedback for S100A8 and Aβ productions. J. Gerontol. A Biol. Sci. Med. Sci. 72 (2017), 319–328.
Manitz, M.-P., Horst, B., Seeliger, S., Strey, A., Skryabin, B.V., Gunzer, M., Frings, W., Schönlau, F., Roth, J., Sorg, C., Nacken, W., Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Mol. Cell. Biol. 23 (2003), 1034–1043.
Mesci, P., Zaïdi, S., Lobsiger, C.S., Millecamps, S., Escartin, C., Seilhean, D., Sato, H., Mallat, M., Boillée, S., System xC− is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice. Brain 138 (2015), 53–68.
Passey, R.J., Williams, E., Lichanska, A.M., Wells, C., Hu, S., Geczy, C.L., Little, M.H., Hume, D.A., A null mutation in the inflammation-associated S100 protein S100A8 causes early resorption of the mouse embryo. J. Immunol. 163 (1999), 2209–2216.
Ryckman, C., Vandal, K., Rouleau, P., Talbot, M., Tessier, P.A., Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J. Immunol. 170 (2003), 3233–3242.
Silverman, J.M., Fernando, S.M., Grad, L.I., Hill, A.F., Turner, B.J., Yerbury, J.J., Cashman, N.R., Disease mechanisms in ALS: misfolded SOD1 transferred through exosome-dependent and exosome-independent pathways. Cell. Mol. Neurobiol. 36 (2016), 377–381.
Urushitani, M., Sik, A., Sakurai, T., Nukina, N., Takahashi, R., Julien, J.-P., Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat. Neurosci. 9 (2006), 108–118.
Vogl, T., Tenbrock, K., Ludwig, S., Leukert, N., Ehrhardt, C., van Zoelen, M.A.D., Nacken, W., Foell, D., van der Poll, T., Sorg, C., Roth, J., Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat. Med. 13 (2007), 1042–1049.
Wang, Siwen, Song, R., Wang, Z., Jing, Z., Wang, Shaoxiong, Ma, J., S100A8/A9 in inflammation. Front. Immunol., 9, 2018, 1298.
Zhang, Y., Chen, K., Sloan, S.A., Bennett, M.L., Scholze, A.R., O'Keeffe, S., Phatnani, H.P., Guarnieri, P., Caneda, C., Ruderisch, N., Deng, S., Liddelow, S.A., Zhang, C., Daneman, R., Maniatis, T., Barres, B.A., Wu, J.Q., An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34 (2014), 11929–11947.
Ziegler, G., Prinz, V., Albrecht, M.W., Harhausen, D., Khojasteh, U., Nacken, W., Endres, M., Dirnagl, U., Nietfeld, W., Trendelenburg, G., Mrp-8 and -14 mediate CNS injury in focal cerebral ischemia. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. Mitochondrial Dis 1792 (2009), 1198–1204.
